Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the fourth quarter and full year 2024 results and the company's business outlook. Speaking today are the company's executive chairman and co-founder, Robert Ortenzio, the company's senior executive vice president of strategic finance and operations, Martin Jackson, and executive vice president and CFO, Michael Malatesta. Management will give you an overview of the quarter and then open the call for questions. Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities, and other statements that refer to Select Medical's plans, expectations, strategies, intentions, and beliefs. These forward-looking statements are based on the information available to management of Select Medical today, and the company assumes no obligation to update these statements if circumstances change. At this time, I will turn the conference call over to Mr. Robert Ortenzio. Thank you, operator. Good morning, everyone. Welcome to Select Medical's earnings call for the fourth quarter of 2024. The fourth quarter concluded a very busy year at Select. On November 25th, we completed the spinoff of Concentra via special stock distribution to Select Medical shareholders. I'd like to thank all of our colleagues at Select and Concentra for their tremendous dedication and hard work to complete this transaction. The historical results of Concentra are now reflected as discontinued operation in Select's consolidated financial statements. We will focus our result...